Metis TechBio Co., Ltd. (HKG:7666)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.94
-0.20 (-1.52%)
Jun 9, 2026, 4:08 PM HKT

Metis TechBio Company Description

Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.

It develops NanoForge, a suite of synergistic technologies that includes novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms.

The company also develops specialized platforms, such as AiTEM, AiLNP and AiRNA that simulate, predict, and interpret nanoscale interactions enabling the design, optimization, and validation of advanced nanomaterials and associated payloads.

It offers foundational dry-wet data layer integrated dry-wet lab infrastructure; model layer METiS AI foundational models; and application layer METiSAgentv.

It serves pharmaceutical companies, biotechnology companies, and medical research institutions. The company was formerly known as Hangzhou Jitai Pharmaceutical Technology Co., Ltd. Metis TechBio Co., Ltd. was incorporated in 2020 and is headquartered in Beijing, China.

Metis TechBio Co., Ltd.
CountryChina
Founded2020
IndustryBiotechnology
SectorHealthcare
CEOTsai-Ta Lai

Contact Details

Address:
Room 201, 2/F, Building 13
Beijing
China
Websitemetistechbio.com

Stock Details

Ticker Symbol7666
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100007LD1
SIC Code2836

Key Executives

NamePosition
Dr. Tsai-Ta LaiCo-founder, Executive Chairman and Chief Executive Officer
Dr. Wenshou WangCo-founder, Chief Operating Officer and Executive Director
Dr. Hongming Chen Sc.D.Co-founder, Chief Research and Development Officer and Executive Director
Dr. Chong FuChief Financial Officer and Board secretary
Dr. Andong LiuVice President and Head of Technology
Dr. Wei XuChief Scientific Officer
Mark Robert HerbertChief Business Officer
Yuk Ting ChengJoint Company Secretary